Salvatore Lenti

552 total citations
19 papers, 198 citations indexed

About

Salvatore Lenti is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Salvatore Lenti has authored 19 papers receiving a total of 198 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Salvatore Lenti's work include Lipoproteins and Cardiovascular Health (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Heart Rate Variability and Autonomic Control (5 papers). Salvatore Lenti is often cited by papers focused on Lipoproteins and Cardiovascular Health (5 papers), Blood Pressure and Hypertension Studies (5 papers) and Heart Rate Variability and Autonomic Control (5 papers). Salvatore Lenti collaborates with scholars based in Italy, United States and Spain. Salvatore Lenti's co-authors include Laura Schiavon, Alberto Mazza, Gianluca Rigatelli, Emilio Ramazzina, Edoardo Casiglia, Domenico Rubello, Danyelle M. Townsend, Fabio Montanaro, Fabio Dell’Avvocata and C. Gennari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Hypertension and Biomedicine & Pharmacotherapy.

In The Last Decade

Salvatore Lenti

16 papers receiving 193 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salvatore Lenti Italy 9 64 36 33 31 30 19 198
Ahmad S. Azhar Saudi Arabia 14 76 1.2× 11 0.3× 35 1.1× 58 1.9× 67 2.2× 39 429
Martino Morbini Italy 11 50 0.8× 52 1.4× 6 0.2× 88 2.8× 45 1.5× 14 292
Yow‐Shieng Uang Taiwan 12 23 0.4× 57 1.6× 23 0.7× 98 3.2× 95 3.2× 23 365
Sayaka Kubo Japan 12 102 1.6× 10 0.3× 17 0.5× 47 1.5× 83 2.8× 26 368
Hanaa M. Abdel-Rahman Egypt 7 53 0.8× 5 0.1× 29 0.9× 12 0.4× 86 2.9× 9 297
Abhilasha Singh India 11 70 1.1× 5 0.1× 15 0.5× 16 0.5× 80 2.7× 21 340
Una-Jovana Vajić Serbia 12 21 0.3× 9 0.3× 71 2.2× 23 0.7× 87 2.9× 24 340
Yu Qin China 5 26 0.4× 11 0.3× 23 0.7× 42 1.4× 68 2.3× 8 431
Tak Fu Tse Hong Kong 7 63 1.0× 9 0.3× 27 0.8× 20 0.6× 77 2.6× 9 378

Countries citing papers authored by Salvatore Lenti

Since Specialization
Citations

This map shows the geographic impact of Salvatore Lenti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salvatore Lenti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salvatore Lenti more than expected).

Fields of papers citing papers by Salvatore Lenti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salvatore Lenti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salvatore Lenti. The network helps show where Salvatore Lenti may publish in the future.

Co-authorship network of co-authors of Salvatore Lenti

This figure shows the co-authorship network connecting the top 25 collaborators of Salvatore Lenti. A scholar is included among the top collaborators of Salvatore Lenti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salvatore Lenti. Salvatore Lenti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Mazza, Alberto, et al.. (2021). EFFECTIVENESS AND SAFETY OF NUTRACEUTICAL COMPOUNDS ADDED TO EZETIMIBE TREATMENT IN HYPERTENSIVE AND HYPER–CHOLESTEROLEMIC SUBJECTS WITH STATIN–INTOLERANCE. Journal of Hypertension. 39(Supplement 1). e371–e371. 3 indexed citations
3.
Mazza, Alberto, et al.. (2019). The Effects of a New Generation of Nutraceutical Compounds on Lipid Profile and Glycaemia in Subjects with Pre-hypertension. High Blood Pressure & Cardiovascular Prevention. 26(4). 345–350. 12 indexed citations
4.
Mazza, Alberto, Danyelle M. Townsend, Laura Schiavon, et al.. (2019). Long-term effect of the perindopril/indapamide/amlodipine single-pill combination on left ventricular hypertrophy in outpatient hypertensive subjects. Biomedicine & Pharmacotherapy. 120. 109539–109539. 10 indexed citations
6.
Mazza, Alberto, et al.. (2018). Effect of Monacolin K and COQ10 supplementation in hypertensive and hypercholesterolemic subjects with metabolic syndrome. Biomedicine & Pharmacotherapy. 105. 992–996. 29 indexed citations
8.
Lanzani, Chiara, Roberto Bigazzi, Laura Zagato, et al.. (2018). HYPERTENSION IN HIGH SCHOOL STUDENTS. Journal of Hypertension. 36(Supplement 1). e17–e17.
9.
Lenti, Salvatore, et al.. (2017). La comunicazione con il paziente e tra professionisti nella gestione del paziente complesso in Medicina Interna. Italian Journal of Medicine. 5(1). 1–1.
10.
Mazza, Alberto, Salvatore Lenti, Laura Schiavon, et al.. (2017). Fixed-Dose Triple Combination of Antihypertensive Drugs Improves Blood Pressure Control: From Clinical Trials to Clinical Practice. Advances in Therapy. 34(4). 975–985. 29 indexed citations
11.
Mazza, Alberto, Arrigo F.G. Cicero, Emilio Ramazzina, et al.. (2017). Nutraceutical approaches to homocysteine lowering in hypertensive subjects at low cardiovascular risk: a multicenter, randomized clinical trial.. PubMed. 30(3). 921–927. 12 indexed citations
12.
Mazza, Alberto, Emilio Ramazzina, Salvatore Lenti, et al.. (2016). [PP.16.29] HOMOCYSTEINE LOWERING THERAPY IN HYPERTENSIVE SUBJECTS AT LOW CARDIOVASCULAR RISK. Journal of Hypertension. 34(Supplement 2). e220–e220. 1 indexed citations
13.
Mazza, Alberto, Salvatore Lenti, Laura Schiavon, et al.. (2016). Asymptomatic hyperuricemia is a strong risk factor for resistant hypertension in elderly subjects from general population. Biomedicine & Pharmacotherapy. 86. 590–594. 17 indexed citations
14.
Mazza, Antonio, Laura Schiavon, Massimo Zuin, et al.. (2016). Effects of the Antihypertensive Fixed-Dose Combinations on an Early Marker of Hypertensive Cardiac Damage in Subjects at Low Cardiovascular Risk. American Journal of Hypertension. 29(8). 969–975. 4 indexed citations
15.
Mazza, Alberto, Salvatore Lenti, Laura Schiavon, et al.. (2015). Nutraceuticals for Serum Lipid and Blood Pressure Control in Hypertensive and Hypercholesterolemic Subjects at Low Cardiovascular Risk. Advances in Therapy. 32(7). 680–690. 22 indexed citations
16.
Masotti, Luca, Filippo Pieralli, Francesco Corradi, et al.. (2014). Characteristics and clinical management of acute pulmonary embolism in real world: findings from TUSCAN-PE Study. Italian Journal of Medicine. 1 indexed citations
17.
Lenti, Salvatore, et al.. (2013). The EDAPA Project (Education of self-measurement of blood pressure) in Grottaglie. SHILAP Revista de lepidopterología. 19–26.
18.
Lenti, Salvatore, et al.. (2010). THE SEE AND TREAT FOR THE MANAGEMENT OF ASYMPTOMATIC PRESSURE INCREASE: PP.14.25. Journal of Hypertension. 28. e255–e256. 1 indexed citations
19.
Nami, R, Sergio Mondillo, Eustachio Agricola, et al.. (2000). Aerobic exercise training fails to reduce blood pressure in nondipper-type hypertension. American Journal of Hypertension. 13(6). 593–600. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026